Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Tormod Nilsen | Cardiac Rehabilitation | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

 

Best Researcher Award

Tormod Nilsen
The Norwegian School of Sport Science

Tormod Nilsen
Affiliation The Norwegian School of Sport Science
Country Norway
Scopus ID 51864003400
Documents 32
Citations 1,486
h-index 17
Subject Area Cardiac Rehabilitation
Event
Cardiology and Cardiovascular Medicine
ORCID
0000-0002-9380-2808

Tormod Nilsen is a researcher affiliated with The Norwegian School of Sport Science whose academic work focuses on exercise science, cardiovascular health, rehabilitation, and clinical research. His research interests include cardiorespiratory fitness, exercise interventions, cardiovascular risk, and rehabilitation among clinical populations. These research areas connect physical activity with preventive and rehabilitative healthcare and contribute to the broader understanding of cardiovascular outcomes. His scholarly profile is represented by 32 documents, 1,486 citations, and an h-index of 17, according to the supplied researcher information.[1]

Abstract

This article presents a scholarly recognition profile of Tormod Nilsen, a researcher affiliated with The Norwegian School of Sport Science. His research is associated with exercise science, cardiovascular health, cardiac rehabilitation, and clinical research involving physical fitness and exercise interventions. His work contributes to understanding relationships between physical activity, cardiovascular function, rehabilitation, and long-term health outcomes. The supplied research profile records 32 documents, 1,486 citations, and an h-index of 17. His academic activities demonstrate interdisciplinary engagement across exercise physiology, cardiovascular medicine, rehabilitation, and related clinical research. This profile summarizes his research areas, contributions, publications, impact, and suitability for researcher recognition.[1]

Keywords

Cardiac rehabilitation; exercise science; cardiovascular health; cardiorespiratory fitness; cardiovascular medicine; rehabilitation research; exercise intervention; clinical research; physical activity; cancer survivorship.

Introduction

Research in exercise science and cardiac rehabilitation increasingly examines the relationship between physical activity, cardiovascular function, clinical risk, and long-term health. Within this interdisciplinary environment, Tormod Nilsen’s research profile is associated with exercise physiology and cardiovascular rehabilitation. His academic work contributes to research examining how structured exercise can be evaluated in relation to physiological fitness and clinical outcomes.[2]

Research Profile

Nilsen’s research profile is centered on exercise-related cardiovascular and rehabilitation questions. Cardiorespiratory fitness provides an important research measure because it can be examined in relation to physical function, cardiovascular risk, and treatment outcomes. His work also connects exercise research with clinical populations, creating an interdisciplinary research direction involving sports science, rehabilitation, cardiology, and preventive health.[3]

Research Contributions

A significant area of relevance in Nilsen’s research is the evaluation of exercise and cardiorespiratory fitness in clinical populations. Research concerning exercise dose and adherence is also important because accurate reporting of exercise exposure supports reproducibility and interpretation of intervention studies. Such methodological considerations strengthen the evidence base for exercise-based rehabilitation and clinical research.[2]

Publications

The research record associated with Nilsen includes collaborative publications addressing exercise therapy, cardiovascular toxicity, cardiorespiratory fitness, exercise dose, adherence, and rehabilitation. These publications demonstrate engagement with both methodological and clinically oriented research questions. The literature also places exercise within emerging cardiovascular and oncology research frameworks, where rehabilitation and physical fitness are increasingly investigated as components of comprehensive patient care.[3][4][5]

Research Impact

The supplied bibliometric profile reports 32 documents, 1,486 citations, and an h-index of 17. These indicators provide quantitative measures of scholarly visibility, although bibliometric values should always be interpreted according to database coverage, publication history, disciplinary citation patterns, and collaboration practices. The research themes represented in the publication record are relevant to exercise science, cardiovascular rehabilitation, and clinical health research.[1]

Award Suitability

The supplied academic profile provides several factors relevant to consideration for a Best Researcher Award in the field of cardiovascular and rehabilitation research. His reported publication activity, citation record, h-index, and research focus provide measurable indicators for evaluation. The interdisciplinary nature of his work also connects sports science with cardiovascular medicine and rehabilitation, making the profile relevant to an award emphasizing research contributions in these areas.[1]

Conclusion

Tormod Nilsen’s academic profile reflects research activity connecting exercise science, cardiovascular health, and rehabilitation. His research contributions include work concerning exercise interventions, cardiorespiratory fitness, cardiovascular outcomes, exercise methodology, and clinical rehabilitation. The supplied bibliometric information further indicates a measurable publication and citation record. Together, these elements provide an appropriate scholarly basis for consideration within a Best Researcher Award framework.[1]

References

  1. Scopus Author Profile. Tormod Nilsen — Author ID 51864003400.
    https://www.scopus.com/pages/authors/51864003400
  2. Original Article (2015.). Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy.
    https://doi.org/10.1111/sms.12543
  3. Original Article (2012.). The effect of strength training volume on satellite cells, myogenic regulatory factors, and growth factors.
    https://doi.org/10.1111/j.1600-0838.2012.01452.x
  4. ORCID. (n.d.). ORCID record:Tormod Nilsen, ORCID iD0000-0002-9380-2808.
    https://orcid.org/0000-0002-9380-2808
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

 

Emilia D’Elia | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Cedric Duval | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Cedric Duval
University of Leeds

Cedric Duval
Affiliation University of Leeds
Country United Kingdom
Scopus ID 55941091300
Documents 43
Citations 1,556
h-index 21
Subject Area Cardiovascular Researches
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-4870-6542

Cedric Duval is presented as a researcher affiliated with the University of Leeds in the United Kingdom, with a stated subject area of cardiovascular research. The supplied academic profile records 43 documents, 1,556 citations, and an h-index of 21. These bibliometric indicators provide quantitative context for evaluating scholarly productivity and research visibility within cardiovascular science. [1]

Abstract

This profile presents Cedric Duval, affiliated with the University of Leeds, as a researcher working within cardiovascular research. The supplied academic indicators report 43 documents, 1,556 citations, and an h-index of 21, providing measurable evidence of publication activity and citation visibility. The profile considers these indicators alongside institutional affiliation, researcher identification information, and the proposed Best Researcher Award context. The assessment emphasizes documented scholarly output, research visibility, and relevance to cardiovascular science. Bibliometric values are presented as supplied and should be interpreted as time-sensitive indicators that may change as databases update records and citations. [1]

Keywords

Cedric Duval, cardiovascular research, cardiovascular medicine, University of Leeds, bibliometrics, scholarly publications, citation impact, h-index, research excellence, Best Researcher Award.

Introduction

Cardiovascular research encompasses scientific investigation into the mechanisms, prevention, diagnosis, treatment, and management of diseases affecting the heart and vascular system. Researchers in this field contribute through experimental studies, clinical investigations, translational research, and interdisciplinary approaches. Academic recognition commonly considers the quality and relevance of research together with evidence of scholarly productivity and influence. [2]

Research Profile

Cedric Duval is identified in the supplied information as being affiliated with the University of Leeds in the United Kingdom. The stated research subject area is cardiovascular research. The associated Scopus Author ID is 55941091300, while the supplied ORCID identifier is 0000-0002-4870-6542. Persistent researcher identifiers help distinguish scholarly records and support accurate attribution of publications across academic information systems. [1] [3]

Research Contributions

The available profile data indicate a sustained body of scholarly output, represented by 43 documents and substantial citation activity. Within cardiovascular research, contributions may be evaluated according to originality, methodological quality, scientific relevance, reproducibility, and potential clinical significance. The supplied bibliometric information provides quantitative context, while publication-level analysis would be required to establish the specific scientific findings and contributions associated with individual works. [1]

Publications

The supplied information attributes 43 documents to the researcher profile. This page does not assign individual article titles, journals, publication dates, or research findings that were not provided in the source information. The Scopus Author ID supplied for this profile can be used to review the indexed publication record, including documents, citations, co-authorship, subject classifications, and related bibliometric information. [1]

Research Impact

The supplied citation count of 1,556 and h-index of 21 indicate measurable visibility within the indexed scholarly record. Citation indicators can assist in describing research influence, although they should be interpreted alongside publication quality, field-specific citation practices, authorship contribution, and publication age. Accordingly, bibliometric measures are most appropriately treated as complementary evidence within a broader academic evaluation rather than as an independent measure of research quality. [1]

Award Suitability

Based on the supplied profile, Cedric Duval demonstrates characteristics relevant to consideration for a Best Researcher Award in cardiovascular research, including documented scholarly output, citation activity, and a stated specialization aligned with cardiovascular science. The reported 43 documents, 1,556 citations, and h-index of 21 provide quantitative evidence for consideration. Final award eligibility and selection should be determined according to the official criteria, verification procedures, and evaluation process established by the organizing body. [1] [4]

Conclusion

Cedric Duval is presented as a cardiovascular research scholar affiliated with the University of Leeds. The supplied bibliometric information records 43 documents, 1,556 citations, and an h-index of 21, providing a concise quantitative profile of scholarly activity. These indicators support consideration within an academic recognition framework, while a complete assessment should incorporate publication quality, research originality, contribution to cardiovascular science, and independently verified evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Cedric Duval, Author ID 55941091300. Scopus.
    https://www.scopus.com/pages/authors/55941091300
  2. Journal article. (2026.) Fibrinogen wags its disordered tail: α chain and thrombosis.
    https://doi.org/10.1182/blood.2026033618
  3. ORCID. (n.d.). ORCID record: Cedric Duval, ORCID iD 0000-0002-4870-6542. ORCID.
    https://orcid.org/0000-0002-4870-6542
  4. Cardiology and Cardiovascular Medicine. (2026.). Academic recognition and award information.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Tao Chen | Cardiovascular Mortality | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award

Fujian Medical University | China 

Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.

Profiles: Scopus | Orcid

Featured Publications

Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.

Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.

Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.

Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.

Irene Aracil | Congenital Heart Defects | Young Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Irene Aracil | Congenital Heart Defects | Young Researcher Award

Hospital Fundación Alcorcón | Spain

Ms. Irene Aracil is a medical specialist in Obstetrics and Gynecology at Hospital Universitario Fundación Alcorcón, recognized for her expertise in maternal and fetal medicine. She completed advanced training in obstetrics, gynecology, and human reproduction at leading Spanish institutions and is pursuing a doctoral degree focused on severe preeclampsia and its long-term cardiovascular effects on women’s health. Her research aims to improve maternal and perinatal outcomes through evidence-based and collaborative approaches. Ms. Aracil Moreno has authored 34 indexed publications and several book chapters, with an h index of 5 and a growing number of citations. Her main areas of study include high risk pregnancies, hypertensive disorders of pregnancy, fertility, and gynecological oncology. She has led and contributed to case control and cohort studies on preeclampsia, maternal outcomes in women with heart disease, and acute kidney injury in pregnancy, as well as meta analyses on triplet pregnancies and uterine sarcomas. Through her multidisciplinary collaborations, she bridges obstetrics and cardiovascular research, providing insights into how pregnancy complications affect long-term health. Her scientific work and clinical dedication continue to advance women’s health, making her a leading young researcher in the field of obstetrics and gynecology.

Profiles: Scopus | Orcid

Featured Publications

Aracil Moreno, I., Prieto-Arévalo, R., Ortega-Abad, V., Martín-Manzano, V., Pérez-Burrel, L., Fraile-López, A., Devesa-Cordero, C., Yllana-Pérez, F., Ortega, M. A., & De León-Luis, J. A. (2024). Maternal and perinatal outcomes in pregnant women with heart disease: A case-control study. Journal of Clinical Medicine, 13(17), 5084.

Aracil Moreno, I., Rodríguez-Benitez, P., Ruiz-Minaya, M., Bernal Claverol, M., Ortega Abad, V., Hernández Martin, C., Pintado Recarte, P., Yllana, F., Oliver-Barrecheguren, C., Alvarez-Mon, M., Ortega, M. A., & De Leon-Luis, J. A. (2024). Perinatal characteristics in patients with severe preeclampsia: A case-control nested cohort study. International Journal of Environmental Research and Public Health.

Aracil Moreno, I., Caballero Martín, S., Ceballos Medina, A., Díaz-Crespo, F. J., Navarro, [initial missing], Ortega Abad, V., León-Luis, J. A., & Mata, F. (2021). Perinatal findings and outcomes in a very rare congenital bulky retroperitoneal Ewing sarcoma: A case report. Pediatric Hematology Oncology Journal.

Rodríguez-Benitez, P., Aracil Moreno, I., Oliver Barrecheguren, C., Cuñarro López, Y., Yllana, F., Pintado Recarte, P., et al. (2021). Maternal-perinatal variables in patients with severe preeclampsia who develop acute kidney injury. Journal of Clinical Medicine, 10(23), 5629.

Ruiz-Minaya, M., Mendizabal-Vicente, E., Vasquez-Jimenez, W., Perez-Burrel, L., Aracil-Moreno, I., Agra-Pujol, C., Bernal-Claverol, M., Martínez-Bernal, B. L., Muñoz-Fernández, M., Morote-Gonzalez, M., Ortega, M. A., Lizarraga-Bonelli, S., & De Leon-Luis, J. A. (2022). Retrospective analysis of patients with gynaecological uterine sarcomas in a tertiary centre. Journal of Personalized Medicine, 12(2), 222.

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Yan Shi | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yan Shi | Congenital Heart Defects | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile:

Scopus

Orcid

🌟 DR. YAN SHI: PIONEERING GENETICS RESEARCHER IN CARDIOVASCULAR DEVELOPMENT 🧬❤️

🎓 EARLY ACADEMIC PURSUITS

Yan Shi , a dedicated scientist from China, embarked on her academic journey in the field of life sciences with an undergraduate degree in Biological Engineering from Shenyang University (2008-2012). She continued to follow her passion for genetics at Hunan Normal University, earning a Master’s Degree in Genetics (2012-2014), and later completed her Ph.D. in Genetics in 2019. Throughout her studies, she developed a strong foundation in molecular biology, focusing on the genetic mechanisms underlying human diseases.

🏥 PROFESSIONAL ENDEAVORS

After obtaining her Ph.D., Dr. Yan Shi advanced her career through postdoctoral research at the Department of Pediatric Cardiac Surgery, Guangdong Provincial People's Hospital (2019-2024). In July 2024, she took on a significant role as a Researcher at the South China Key Laboratory of Structural Heart Disease, where she continues to contribute to groundbreaking cardiovascular research.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CONGENITAL HEART DEFECTS

Dr. Yan Shi's primary research focuses on the molecular mechanisms of congenital and familial heart diseases, especially:

  • Tetralogy of Fallot (TOF)

  • Familial Dilated Cardiomyopathy (DCM)

  • Wnt signaling pathways in cardiac development

  • Single coronary artery animal models

She has successfully led and participated in several national-level projects, including:

  • SORBS2's role in familial dilated cardiomyopathy via the AKT pathway (2024-2027).

  • NOTCH1 point mutations leading to Tetralogy of Fallot (2022-2024).

  • Establishing an animal model for single coronary artery using mice (2020-2022).

🏅 IMPACT AND INFLUENCE

Dr. Yan Shi’s work has been widely recognized in the academic community. She has published several influential papers in reputable journals as the first, co-first, or corresponding author, covering:

  • Wnt signaling and cardiomyocyte differentiation

  • NOTCH1 mutations in congenital heart disease

  • Genetic polymorphisms in BVES associated with Tetralogy of Fallot

Additionally, she was a contributor to a team that won the First-Class Guangdong Natural Science Award (2020) for their research on genes regulating cardiovascular development.

📚 ACADEMIC CITES

Her published research has been cited in various genetic, developmental biology, and cardiovascular journals. Some of her notable publications include:

  • "Variants and Molecular Mechanism of NOTCH1 in Congenital Heart Disease" – Corresponding Author

  • "Novel biphasic mechanism of the canonical Wnt signaling component PYGO2 promotes cardiomyocyte differentiation" – First Author

  • "Structure and function of Pygo in organ development" – First Author

🚀 LEGACY AND FUTURE CONTRIBUTIONS

As an emerging leader in the field of genetic cardiology, Dr. Yan Shi’s legacy is shaped by her contributions to understanding the genetic underpinnings of heart disease, which hold promise for improving clinical diagnostics and therapies for congenital heart conditions. Her future work is expected to explore further genetic pathways and their therapeutic targeting, potentially leading to personalized treatments for heart diseases.

📑 NOTABLE PUBLICATIONS

"Novel biphasic mechanism of the canonical Wnt signalling component PYGO2 promotes cardiomyocyte differentiation from hUCMSCs"

Authors: Y Shi, B Qin, X Fan, Y Li, Y Wang, W Yuan, Z Jiang, P Zhu, J Chen, Y Chen, F Li, Y Wan
Journal: Cell and Tissue Research
Year: 2023

"Structure and function of Pygo in organ development dependent and independent Wnt signalling"

Authors: Y Shi, X Wu, S Zhu, H Huang, J Zhuang, H Yuan, W Yuan, P Zhu
Journal: Biochemical Society Transactions
Year: 2020

Yaodong Li | Electrophysiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li, Department of Pacing and Electrophysiology, the First Affiliated Hospital of Xinjiang Medical University, China

Prof. Yaodong Li is a leading expert in cardiac electrophysiology at the First Affiliated Hospital of Xinjiang Medical University, China. He holds a Doctor of Medicine in Cardiology from Xinjiang Medical University and serves as Professor and Chief Physician at the Cardiovascular Disease Center. Renowned for his work in pacing and atrial fibrillation, he has received numerous national and regional awards for scientific and clinical innovation. With several projects funded by the National Natural Science Foundation of China, Prof. Li is recognized as a “Research-oriented Talent” and continues to advance cardiovascular medicine through research, clinical excellence, and education.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Yaodong Li embarked on his medical journey at Xinjiang Medical University, where he pursued a Doctor of Medicine in Cardiology from September 2008 to July 2012 in Urumqi, Xinjiang. His foundational years in this esteemed institution laid the groundwork for a career deeply rooted in cardiovascular research and clinical excellence. During his academic training, he quickly distinguished himself through rigorous study and early contributions to scientific research.

📚 PROFESSIONAL ENDEAVORS:

Since August 2018, Prof. Li has served as a Professor and Chief Physician at the Cardiovascular Disease Center of Xinjiang Medical University. His professional journey reflects an upward trajectory marked by commitment to patient care, cutting-edge electrophysiological techniques, and leadership in academic medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ELECTROPHYSIOLOGY:

Prof. Li’s core expertise lies in cardiac electrophysiology, pacing, and atrial fibrillation management. He has been actively involved in national and regional scientific research projects, showcasing a strong focus on innovative treatment modalities and clinical electrophysiological advancements. His research is widely respected for its clinical relevance and technical innovation.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s work has earned him numerous awards and honors, demonstrating his prominence within the national and regional cardiology communities:

  • 2008–2023: Multiple Scientific and Technological Progress Awards from Urumqi City and Xinjiang Autonomous Region

  • 2012: Awarded for Excellent Paper at the 10th National Academic Biannual Meeting of the Chinese Society of Electrophysiology and Pacing

  • 2013 & 2014: Second Prize at the Xinjiang Natural Science Awards (Ranked 2nd)

  • 2022: Recognized with the “Elite in Atrial Fibrillation Prevention and Treatment” Clinical Technology Innovation Honor

  • 2023: Swept honors at the 14th Pacing Summit Forum including:

    • First Prize for Excellent ICD Case

    • Second Prize for Leadless Excellent Case

    • Excellent Young Physician Award

🔎 ACADEMIC CITES AND RECOGNITION:

His studies have contributed significantly to Chinese cardiovascular literature, often cited in national medical conferences and publications. His rankings in award listings reflect not only quality research but also peer acknowledgment of his impact on clinical practice and knowledge dissemination.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Yaodong Li represents the future of electrophysiology in China—a visionary in device therapy, pacing technologies, and clinical research leadership. As a “Research-oriented Talent” honored by the Chinese Research Hospital Association in 2024, he is set to:

  • Inspire a new generation of electrophysiologists

  • Spearhead multicenter research projects on atrial fibrillation and ICD innovations

  • Promote global collaborations in cardiac rhythm management

🌍CONCLUSION:

Prof. Yaodong Li stands as a distinguished figure in the field of cardiac electrophysiology, blending clinical expertise with groundbreaking research and innovation. His dedication to advancing pacing techniques and atrial fibrillation treatment has earned him national recognition, prestigious awards, and significant research funding. As a mentor, physician, and scientist, he continues to shape the future of cardiovascular care in China and beyond. With a passion for excellence and a commitment to improving patient outcomes, Prof. Li remains a true pioneer and inspiration in the world of cardiology.

TOP NOTABLE PUBLICATIONS

Title: MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation
Authors: Wang, Lu; Sang, Wanyue; Jian, Yi; …; Tang, Baopeng; Li, Yaodong
Journal: Journal of Molecular and Cellular Cardiology
Year: 2025

Title: The impact of frailty on the prognosis of chronic heart failure patients treated with cardiac resynchronization therapy defibrillator implantation
Authors: Gao, Liang; Lyu, Huasheng; Tang, Baopeng; …; Zukela, Tuerhong; Lu, Yanmei
Journal: Zhonghua Nei Ke Za Zhi (Chinese Journal of Internal Medicine)
Year: 2025

Title: Effect of renal denervation on atrial neural and structural remodeling in rats with obesity-related atrial fibrillation and its mechanism
Authors: Jian, Yi; Sang, Wanyue; Wang, Lu; …; Zhang, Xing; Li, Yaodong
Journal: Chinese Journal of Pathophysiology
Year: 2024

Title: Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
Authors: Han, Yafan; Shao, Mingliang; Yang, Hang; …; Tang, Baopeng; Li, Yaodong
Journal: Scientific Reports
Year: 2024

Title: A case of endocardial dissection caused by Micra implantation
Authors: Zhang, Jianghua; Shang, Shuai; Dong, Zhenyu; …; Xiaokereti, Jiasuoer; Tang, Baopeng
Journal: BMC Cardiovascular Disorders
Year: 2024

Title: Strategy Optimization for a Combined Procedure in Patients With Atrial Fibrillation: The COMBINATION Randomized Clinical Trial
Authors: Du, Xianfeng; Chu, Huimin; Yang, Bing; …; Yu, Xinzhi; Chen, Xiaomin
Journal: JAMA Network Open
Year: 2024

Title: CALCOCO2 prevents AngII-induced atrial remodeling by regulating the interaction between mitophagy and mitochondrial stress
Authors: Sang, Wanyue; Yan, Xiaoji; Wang, Lu; …; Tang, Baopeng; Li, Yaodong
Journal: International Immunopharmacology
Year: 2024